1. CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner
- Author
-
Zhen Huang, Chen Wang, Shi Ziyu, Jie Zhu, Yuqian Zhang, Mingyue Li, Junfeng Zhang, and Jiangning Chen
- Subjects
0301 basic medicine ,Core Binding Factor Alpha 1 Subunit ,Biology ,Article ,Core Binding Factor beta Subunit ,Metastasis ,Transcriptome ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,Gene expression ,Transcriptional regulation ,medicine ,Animals ,Humans ,Molecular Biology ,Transcription factor ,Cell Proliferation ,Uridine Phosphorylase ,Cell growth ,Intracellular Signaling Peptides and Proteins ,Cell Biology ,medicine.disease ,Survival Analysis ,digestive system diseases ,RUNX2 ,030104 developmental biology ,030220 oncology & carcinogenesis ,Disease Progression ,Cancer research ,Colorectal Neoplasms - Abstract
Colorectal cancer (CRC) is commonly associated with aberrant transcription regulation, but characteristics of the dysregulated transcription factors in CRC pathogenesis remain to be elucidated. In the present study, core-binding factor β (CBFβ) is found to be significantly upregulated in human CRC tissues and correlates with poor survival rate of CRC patients. Mechanistically, CBFβ is found to promote CRC cell proliferation, migration, invasion, and inhibit cell apoptosis in a RUNX2-dependent way. Transcriptome studies reveal that CBFβ and RUNX2 form a transcriptional complex that activates gene expression of OPN, FAM129A, and UPP1. Furthermore, CBFβ significantly promotes CRC tumor growth and live metastasis in a mouse xenograft model and a mouse liver metastasis model. In addition, tumor-suppressive miR-143/145 are found to inhibit CBFβ expression by specifically targeting its 3'-UTR region. Consistently, an inverse correlation between miR-143/miR-145 and CBFβ expression levels is present in CRC patients. Taken together, this study uncovers a novel regulatory role of CBFβ-RUNX2 complex in the transcriptional activation of OPN, FAM129A, and UPP1 during CRC development, and may provide important insights into CRC pathogenesis.
- Published
- 2021
- Full Text
- View/download PDF